Gene Symbol | Gene ID | Gene Info |
---|---|---|
HOXC8
|
ENSG00000037965.4 | homeobox C8 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_54402288_54402544 | HOXC8 | 416 | 0.594755 | 0.72 | 2.7e-02 | Click! |
chr12_54398329_54398480 | HOXC8 | 4428 | 0.067583 | 0.71 | 3.1e-02 | Click! |
chr12_54401824_54401975 | HOXC8 | 933 | 0.269281 | 0.67 | 4.9e-02 | Click! |
chr12_54402091_54402242 | HOXC8 | 666 | 0.394225 | 0.57 | 1.1e-01 | Click! |
chr12_54404190_54404341 | HOXC8 | 1433 | 0.162959 | 0.57 | 1.1e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr9_18474095_18474958 | 2.50 |
ADAMTSL1 |
ADAMTS-like 1 |
295 |
0.95 |
chr10_33620428_33620906 | 2.43 |
NRP1 |
neuropilin 1 |
2643 |
0.37 |
chr15_96878987_96879612 | 2.00 |
ENSG00000222651 |
. |
2809 |
0.21 |
chr4_157891142_157892336 | 1.85 |
PDGFC |
platelet derived growth factor C |
316 |
0.91 |
chr12_59311038_59311457 | 1.83 |
LRIG3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
2080 |
0.36 |
chr7_41740779_41741576 | 1.77 |
INHBA |
inhibin, beta A |
970 |
0.56 |
chrX_114467670_114468385 | 1.73 |
LRCH2 |
leucine-rich repeats and calponin homology (CH) domain containing 2 |
601 |
0.77 |
chr3_87036535_87037613 | 1.73 |
VGLL3 |
vestigial like 3 (Drosophila) |
2778 |
0.42 |
chrX_28605228_28605520 | 1.72 |
IL1RAPL1 |
interleukin 1 receptor accessory protein-like 1 |
142 |
0.98 |
chr11_121967218_121967559 | 1.71 |
ENSG00000207971 |
. |
3164 |
0.21 |
chr6_152701268_152701555 | 1.66 |
SYNE1-AS1 |
SYNE1 antisense RNA 1 |
270 |
0.91 |
chr8_19148668_19149118 | 1.64 |
SH2D4A |
SH2 domain containing 4A |
22235 |
0.28 |
chr1_243415347_243415602 | 1.62 |
CEP170 |
centrosomal protein 170kDa |
1148 |
0.47 |
chr10_114714851_114715858 | 1.61 |
RP11-57H14.2 |
|
3720 |
0.26 |
chr7_130596201_130596683 | 1.59 |
ENSG00000226380 |
. |
34144 |
0.19 |
chr8_42063953_42065062 | 1.59 |
PLAT |
plasminogen activator, tissue |
576 |
0.71 |
chr2_158113918_158114875 | 1.58 |
GALNT5 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5) |
286 |
0.93 |
chr9_12859535_12860149 | 1.55 |
ENSG00000222658 |
. |
25478 |
0.2 |
chr21_17677767_17678526 | 1.53 |
ENSG00000201025 |
. |
21057 |
0.28 |
chr15_99788624_99789059 | 1.52 |
TTC23 |
tetratricopeptide repeat domain 23 |
895 |
0.51 |
chr7_94025506_94025990 | 1.50 |
COL1A2 |
collagen, type I, alpha 2 |
1875 |
0.46 |
chr4_114899439_114899761 | 1.46 |
ARSJ |
arylsulfatase family, member J |
552 |
0.84 |
chr7_78398482_78399243 | 1.41 |
MAGI2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
1534 |
0.56 |
chr3_157250255_157250502 | 1.37 |
VEPH1 |
ventricular zone expressed PH domain-containing 1 |
1017 |
0.61 |
chr6_85823864_85824548 | 1.37 |
NT5E |
5'-nucleotidase, ecto (CD73) |
335603 |
0.01 |
chr15_70994402_70994652 | 1.37 |
UACA |
uveal autoantigen with coiled-coil domains and ankyrin repeats |
93 |
0.98 |
chr20_14317720_14318261 | 1.36 |
FLRT3 |
fibronectin leucine rich transmembrane protein 3 |
264 |
0.94 |
chr2_164591489_164591640 | 1.36 |
FIGN |
fidgetin |
953 |
0.74 |
chr7_80547175_80548098 | 1.35 |
SEMA3C |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C |
863 |
0.76 |
chr2_36581700_36582677 | 1.34 |
CRIM1 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
881 |
0.74 |
chr9_27276437_27276611 | 1.33 |
EQTN |
equatorin, sperm acrosome associated |
20610 |
0.24 |
chr6_121757423_121758012 | 1.33 |
GJA1 |
gap junction protein, alpha 1, 43kDa |
879 |
0.59 |
chr8_49832237_49832502 | 1.33 |
SNAI2 |
snail family zinc finger 2 |
1619 |
0.54 |
chr6_19691587_19692480 | 1.32 |
ENSG00000200957 |
. |
49273 |
0.18 |
chr12_88972313_88972545 | 1.29 |
KITLG |
KIT ligand |
1809 |
0.39 |
chr15_37179413_37179956 | 1.28 |
ENSG00000212511 |
. |
34843 |
0.22 |
chr11_27722222_27723091 | 1.28 |
BDNF |
brain-derived neurotrophic factor |
56 |
0.98 |
chr18_56245541_56245920 | 1.27 |
RP11-126O1.2 |
|
21428 |
0.14 |
chr5_91977319_91977616 | 1.27 |
ENSG00000221810 |
. |
75753 |
0.13 |
chr8_127837007_127837644 | 1.25 |
ENSG00000212451 |
. |
153558 |
0.04 |
chr3_55514769_55515136 | 1.24 |
WNT5A |
wingless-type MMTV integration site family, member 5A |
272 |
0.94 |
chr7_120631344_120631706 | 1.24 |
CPED1 |
cadherin-like and PC-esterase domain containing 1 |
1849 |
0.35 |
chr2_216299709_216300678 | 1.24 |
FN1 |
fibronectin 1 |
597 |
0.55 |
chr15_30112674_30113382 | 1.23 |
TJP1 |
tight junction protein 1 |
723 |
0.64 |
chr3_126500993_126501380 | 1.23 |
CHCHD6 |
coiled-coil-helix-coiled-coil-helix domain containing 6 |
51779 |
0.16 |
chr5_174162455_174162926 | 1.23 |
MSX2 |
msh homeobox 2 |
11085 |
0.25 |
chr18_53089837_53090372 | 1.23 |
TCF4 |
transcription factor 4 |
361 |
0.89 |
chr14_52707563_52708006 | 1.21 |
PTGDR |
prostaglandin D2 receptor (DP) |
26647 |
0.22 |
chr9_21677527_21678485 | 1.20 |
ENSG00000244230 |
. |
21307 |
0.21 |
chr17_75316367_75316959 | 1.20 |
SEPT9 |
septin 9 |
268 |
0.93 |
chr1_7130330_7130574 | 1.20 |
RP11-334N17.1 |
|
56113 |
0.15 |
chr7_151433344_151433930 | 1.20 |
PRKAG2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
237 |
0.95 |
chr4_71588718_71588869 | 1.19 |
RUFY3 |
RUN and FYVE domain containing 3 |
421 |
0.76 |
chr3_181434209_181434555 | 1.19 |
SOX2 |
SRY (sex determining region Y)-box 2 |
4660 |
0.26 |
chr18_55468661_55468977 | 1.19 |
ATP8B1 |
ATPase, aminophospholipid transporter, class I, type 8B, member 1 |
1508 |
0.47 |
chr11_121969171_121969347 | 1.19 |
ENSG00000207971 |
. |
1293 |
0.36 |
chr17_32582682_32583141 | 1.19 |
AC005549.3 |
Uncharacterized protein |
605 |
0.41 |
chr4_151500337_151500655 | 1.18 |
RP11-1336O20.2 |
|
255 |
0.93 |
chr6_19838575_19839711 | 1.16 |
RP1-167F1.2 |
|
168 |
0.95 |
chr7_27191312_27191528 | 1.16 |
HOXA-AS3 |
HOXA cluster antisense RNA 3 |
1749 |
0.13 |
chr5_169406633_169406826 | 1.16 |
FAM196B |
family with sequence similarity 196, member B |
1015 |
0.64 |
chr4_41215270_41215769 | 1.15 |
APBB2 |
amyloid beta (A4) precursor protein-binding, family B, member 2 |
956 |
0.59 |
chr17_59476045_59476898 | 1.14 |
RP11-332H18.4 |
|
260 |
0.74 |
chr10_60273912_60274168 | 1.14 |
BICC1 |
bicaudal C homolog 1 (Drosophila) |
1140 |
0.65 |
chr12_10868992_10869331 | 1.13 |
YBX3 |
Y box binding protein 3 |
6745 |
0.18 |
chr3_15837119_15837337 | 1.13 |
ANKRD28 |
ankyrin repeat domain 28 |
800 |
0.67 |
chr1_65005729_65006114 | 1.12 |
ENSG00000264470 |
. |
39609 |
0.19 |
chr14_39716196_39716541 | 1.12 |
MIA2 |
melanoma inhibitory activity 2 |
13049 |
0.14 |
chr1_163040363_163040678 | 1.11 |
RGS4 |
regulator of G-protein signaling 4 |
1314 |
0.56 |
chr9_21558481_21558945 | 1.10 |
MIR31HG |
MIR31 host gene (non-protein coding) |
955 |
0.56 |
chr9_22008020_22008450 | 1.10 |
CDKN2B |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
717 |
0.61 |
chr3_149094469_149095370 | 1.10 |
TM4SF1-AS1 |
TM4SF1 antisense RNA 1 |
646 |
0.47 |
chr21_17960305_17960805 | 1.09 |
ENSG00000207863 |
. |
2002 |
0.4 |
chr22_36233928_36234199 | 1.08 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
2202 |
0.43 |
chr11_121968787_121969071 | 1.08 |
ENSG00000207971 |
. |
1623 |
0.3 |
chr1_153584096_153584410 | 1.08 |
S100A16 |
S100 calcium binding protein A16 |
1306 |
0.22 |
chr8_92612283_92612746 | 1.07 |
ENSG00000200151 |
. |
5321 |
0.33 |
chr3_149372263_149372653 | 1.07 |
WWTR1-AS1 |
WWTR1 antisense RNA 1 |
2349 |
0.24 |
chr4_81191707_81191903 | 1.07 |
FGF5 |
fibroblast growth factor 5 |
4012 |
0.29 |
chr4_23890359_23890765 | 1.06 |
PPARGC1A |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
1096 |
0.66 |
chr2_190042287_190042516 | 1.05 |
COL5A2 |
collagen, type V, alpha 2 |
2204 |
0.37 |
chr5_98111445_98111873 | 1.05 |
RGMB |
repulsive guidance molecule family member b |
2320 |
0.3 |
chr3_93895824_93896204 | 1.05 |
ENSG00000253062 |
. |
78604 |
0.1 |
chr5_124078870_124079512 | 1.05 |
ZNF608 |
zinc finger protein 608 |
1023 |
0.42 |
chr4_89977525_89978081 | 1.05 |
FAM13A |
family with sequence similarity 13, member A |
508 |
0.85 |
chr4_71589225_71589655 | 1.05 |
RUFY3 |
RUN and FYVE domain containing 3 |
1068 |
0.4 |
chr18_53090404_53090609 | 1.03 |
TCF4 |
transcription factor 4 |
763 |
0.7 |
chr13_24145467_24145689 | 1.03 |
TNFRSF19 |
tumor necrosis factor receptor superfamily, member 19 |
775 |
0.77 |
chr4_125632186_125632438 | 1.02 |
ANKRD50 |
ankyrin repeat domain 50 |
1575 |
0.58 |
chr15_97778812_97779147 | 1.02 |
ENSG00000242863 |
. |
117748 |
0.06 |
chr18_53525579_53526226 | 1.01 |
TCF4 |
transcription factor 4 |
193884 |
0.03 |
chr10_33622034_33622426 | 1.01 |
NRP1 |
neuropilin 1 |
1080 |
0.63 |
chr15_56208525_56208789 | 1.01 |
NEDD4 |
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase |
649 |
0.78 |
chr4_134068181_134068851 | 1.01 |
PCDH10 |
protocadherin 10 |
1954 |
0.52 |
chr4_187590867_187591207 | 1.01 |
FAT1 |
FAT atypical cadherin 1 |
53972 |
0.15 |
chr19_6076963_6077580 | 1.00 |
CTC-232P5.3 |
|
9307 |
0.15 |
chr1_227504354_227504526 | 1.00 |
CDC42BPA |
CDC42 binding protein kinase alpha (DMPK-like) |
443 |
0.9 |
chr8_49833429_49833759 | 1.00 |
SNAI2 |
snail family zinc finger 2 |
394 |
0.92 |
chr6_121756849_121757212 | 0.99 |
GJA1 |
gap junction protein, alpha 1, 43kDa |
192 |
0.94 |
chr6_38230060_38230313 | 0.99 |
ENSG00000200706 |
. |
55136 |
0.16 |
chr5_16933613_16934070 | 0.99 |
MYO10 |
myosin X |
2206 |
0.34 |
chr18_74798828_74799607 | 0.99 |
MBP |
myelin basic protein |
18000 |
0.27 |
chr2_199965342_199965661 | 0.98 |
ENSG00000238698 |
. |
90281 |
0.1 |
chr5_158488269_158488591 | 0.98 |
EBF1 |
early B-cell factor 1 |
38271 |
0.17 |
chr13_24146066_24146217 | 0.98 |
TNFRSF19 |
tumor necrosis factor receptor superfamily, member 19 |
1338 |
0.59 |
chr20_47961894_47962163 | 0.97 |
ENSG00000212304 |
. |
64808 |
0.08 |
chr15_39803785_39804214 | 0.97 |
THBS1 |
thrombospondin 1 |
69281 |
0.1 |
chr13_65834890_65835427 | 0.97 |
ENSG00000221685 |
. |
603147 |
0.0 |
chr3_87039220_87039752 | 0.97 |
VGLL3 |
vestigial like 3 (Drosophila) |
366 |
0.93 |
chr8_49447973_49448420 | 0.96 |
RP11-770E5.1 |
|
15931 |
0.3 |
chr21_17909068_17909746 | 0.96 |
ENSG00000207638 |
. |
2002 |
0.33 |
chr19_39465324_39465724 | 0.96 |
FBXO17 |
F-box protein 17 |
1026 |
0.37 |
chr10_93443563_93443860 | 0.96 |
PPP1R3C |
protein phosphatase 1, regulatory subunit 3C |
50900 |
0.16 |
chr12_64238850_64239338 | 0.95 |
SRGAP1 |
SLIT-ROBO Rho GTPase activating protein 1 |
553 |
0.72 |
chr22_46461260_46461448 | 0.95 |
RP6-109B7.4 |
|
4417 |
0.11 |
chr10_29824642_29824876 | 0.95 |
ENSG00000207612 |
. |
9267 |
0.19 |
chr6_148829582_148830289 | 0.95 |
ENSG00000223322 |
. |
15441 |
0.29 |
chr5_88120627_88121096 | 0.94 |
MEF2C |
myocyte enhancer factor 2C |
704 |
0.78 |
chr12_66286178_66286489 | 0.94 |
RP11-366L20.2 |
Uncharacterized protein |
10386 |
0.18 |
chr2_151336714_151337073 | 0.94 |
RND3 |
Rho family GTPase 3 |
5003 |
0.36 |
chr16_86604206_86604444 | 0.94 |
RP11-463O9.5 |
|
2958 |
0.2 |
chr15_72529055_72529849 | 0.94 |
PKM |
pyruvate kinase, muscle |
5288 |
0.17 |
chr1_45083000_45083241 | 0.94 |
RNF220 |
ring finger protein 220 |
8878 |
0.17 |
chr10_33620140_33620362 | 0.93 |
NRP1 |
neuropilin 1 |
3059 |
0.34 |
chr7_116141197_116141631 | 0.93 |
CAV2 |
caveolin 2 |
1580 |
0.29 |
chr1_95388573_95389173 | 0.93 |
CNN3 |
calponin 3, acidic |
2464 |
0.27 |
chr15_60683019_60683395 | 0.93 |
ANXA2 |
annexin A2 |
119 |
0.98 |
chr5_57752262_57752636 | 0.92 |
PLK2 |
polo-like kinase 2 |
3638 |
0.28 |
chr12_132268914_132269167 | 0.92 |
ENSG00000200516 |
. |
16939 |
0.16 |
chr12_91574306_91575101 | 0.92 |
DCN |
decorin |
50 |
0.99 |
chr2_5830994_5831186 | 0.91 |
AC108025.2 |
|
88 |
0.88 |
chr12_56916774_56917003 | 0.91 |
RBMS2 |
RNA binding motif, single stranded interacting protein 2 |
1105 |
0.41 |
chr4_123795073_123795451 | 0.91 |
RP11-170N16.3 |
|
10605 |
0.18 |
chr6_155005040_155005564 | 0.90 |
SCAF8 |
SR-related CTD-associated factor 8 |
49157 |
0.17 |
chr9_111205795_111206154 | 0.90 |
ENSG00000222512 |
. |
84765 |
0.11 |
chr6_8434475_8434734 | 0.89 |
SLC35B3 |
solute carrier family 35 (adenosine 3'-phospho 5'-phosphosulfate transporter), member B3 |
1112 |
0.69 |
chr12_85305306_85305778 | 0.89 |
SLC6A15 |
solute carrier family 6 (neutral amino acid transporter), member 15 |
261 |
0.96 |
chr8_25042452_25043634 | 0.89 |
DOCK5 |
dedicator of cytokinesis 5 |
663 |
0.75 |
chr1_98496636_98496977 | 0.88 |
ENSG00000225206 |
. |
14101 |
0.3 |
chr22_46462951_46463814 | 0.88 |
RP6-109B7.4 |
|
2389 |
0.16 |
chr18_74300716_74301068 | 0.88 |
LINC00908 |
long intergenic non-protein coding RNA 908 |
60018 |
0.12 |
chr4_88939495_88939878 | 0.88 |
PKD2 |
polycystic kidney disease 2 (autosomal dominant) |
10866 |
0.19 |
chr5_78808053_78808300 | 0.88 |
HOMER1 |
homer homolog 1 (Drosophila) |
441 |
0.86 |
chr19_30719241_30719606 | 0.88 |
ZNF536 |
zinc finger protein 536 |
2 |
0.73 |
chr11_84598351_84598627 | 0.88 |
DLG2 |
discs, large homolog 2 (Drosophila) |
35735 |
0.2 |
chr19_49661333_49661989 | 0.87 |
TRPM4 |
transient receptor potential cation channel, subfamily M, member 4 |
562 |
0.58 |
chr5_115313493_115313761 | 0.87 |
AQPEP |
Aminopeptidase Q |
15436 |
0.17 |
chr6_3749707_3750198 | 0.87 |
RP11-420L9.5 |
|
1393 |
0.41 |
chr5_31193803_31195028 | 0.87 |
CDH6 |
cadherin 6, type 2, K-cadherin (fetal kidney) |
558 |
0.85 |
chr2_190068990_190069191 | 0.87 |
COL5A2 |
collagen, type V, alpha 2 |
24485 |
0.21 |
chr10_92679511_92679800 | 0.87 |
ANKRD1 |
ankyrin repeat domain 1 (cardiac muscle) |
1378 |
0.39 |
chr7_17720120_17720505 | 0.87 |
SNX13 |
sorting nexin 13 |
259779 |
0.02 |
chr3_33318777_33319866 | 0.87 |
FBXL2 |
F-box and leucine-rich repeat protein 2 |
353 |
0.91 |
chr6_114181963_114182196 | 0.87 |
MARCKS |
myristoylated alanine-rich protein kinase C substrate |
3538 |
0.24 |
chr1_68697735_68698156 | 0.87 |
WLS |
wntless Wnt ligand secretion mediator |
18 |
0.98 |
chr13_24079253_24079588 | 0.86 |
TNFRSF19 |
tumor necrosis factor receptor superfamily, member 19 |
65089 |
0.13 |
chr6_163840513_163841070 | 0.86 |
QKI |
QKI, KH domain containing, RNA binding |
3375 |
0.39 |
chr1_221165731_221165981 | 0.86 |
HLX |
H2.0-like homeobox |
111272 |
0.06 |
chr3_64670816_64671530 | 0.86 |
ADAMTS9-AS2 |
ADAMTS9 antisense RNA 2 |
369 |
0.87 |
chr4_138450639_138450790 | 0.86 |
PCDH18 |
protocadherin 18 |
2851 |
0.43 |
chr8_16689434_16690090 | 0.86 |
ENSG00000264092 |
. |
31243 |
0.24 |
chr6_8109014_8109165 | 0.86 |
EEF1E1 |
eukaryotic translation elongation factor 1 epsilon 1 |
6278 |
0.27 |
chr7_95402477_95402695 | 0.86 |
DYNC1I1 |
dynein, cytoplasmic 1, intermediate chain 1 |
670 |
0.81 |
chr5_172753269_172753420 | 0.86 |
STC2 |
stanniocalcin 2 |
456 |
0.82 |
chr11_121970307_121971111 | 0.85 |
ENSG00000207971 |
. |
157 |
0.79 |
chr14_52121528_52121679 | 0.85 |
FRMD6 |
FERM domain containing 6 |
2905 |
0.27 |
chr3_97590789_97591003 | 0.85 |
CRYBG3 |
beta-gamma crystallin domain containing 3 |
4923 |
0.28 |
chr2_221969079_221969387 | 0.85 |
EPHA4 |
EPH receptor A4 |
398047 |
0.01 |
chr1_24476638_24476996 | 0.85 |
IL22RA1 |
interleukin 22 receptor, alpha 1 |
7206 |
0.17 |
chr1_179111876_179112093 | 0.84 |
ABL2 |
c-abl oncogene 2, non-receptor tyrosine kinase |
195 |
0.95 |
chr3_44063258_44064101 | 0.84 |
ENSG00000252980 |
. |
48900 |
0.17 |
chr2_227590884_227591406 | 0.84 |
ENSG00000263363 |
. |
67636 |
0.11 |
chr8_23711375_23711668 | 0.84 |
STC1 |
stanniocalcin 1 |
303 |
0.92 |
chr12_91576386_91576586 | 0.84 |
DCN |
decorin |
0 |
0.99 |
chr12_19358566_19358717 | 0.84 |
PLEKHA5 |
pleckstrin homology domain containing, family A member 5 |
382 |
0.89 |
chr12_97469704_97469855 | 0.84 |
ENSG00000202368 |
. |
96372 |
0.09 |
chr6_88875424_88876640 | 0.84 |
CNR1 |
cannabinoid receptor 1 (brain) |
46 |
0.99 |
chr15_38547811_38548278 | 0.84 |
SPRED1 |
sprouty-related, EVH1 domain containing 1 |
2662 |
0.42 |
chr4_41204622_41204773 | 0.84 |
APBB2 |
amyloid beta (A4) precursor protein-binding, family B, member 2 |
11778 |
0.2 |
chr22_47486867_47487445 | 0.84 |
ENSG00000221672 |
. |
243353 |
0.02 |
chr1_201509442_201509672 | 0.84 |
CSRP1 |
cysteine and glycine-rich protein 1 |
30973 |
0.13 |
chr1_196621837_196622284 | 0.84 |
CFH |
complement factor H |
874 |
0.67 |
chr1_224075422_224075812 | 0.83 |
TP53BP2 |
tumor protein p53 binding protein, 2 |
41943 |
0.17 |
chr1_8262367_8262761 | 0.83 |
ENSG00000200975 |
. |
4093 |
0.27 |
chr11_12714851_12715219 | 0.83 |
TEAD1 |
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
17985 |
0.26 |
chr12_117036919_117037510 | 0.83 |
MAP1LC3B2 |
microtubule-associated protein 1 light chain 3 beta 2 |
23558 |
0.24 |
chr3_114619517_114619967 | 0.83 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
141624 |
0.05 |
chr7_70201396_70202343 | 0.83 |
AUTS2 |
autism susceptibility candidate 2 |
7744 |
0.34 |
chr4_143739251_143739537 | 0.83 |
INPP4B |
inositol polyphosphate-4-phosphatase, type II, 105kDa |
28049 |
0.27 |
chr9_16726683_16727481 | 0.82 |
RP11-62F24.2 |
|
270 |
0.85 |
chr4_54063057_54063462 | 0.82 |
ENSG00000207385 |
. |
68475 |
0.13 |
chr2_38828054_38829790 | 0.82 |
AC011247.3 |
|
182 |
0.89 |
chr1_81703498_81704139 | 0.82 |
ENSG00000223026 |
. |
13656 |
0.28 |
chr15_39874864_39875069 | 0.82 |
THBS1 |
thrombospondin 1 |
1672 |
0.37 |
chr8_122649996_122650341 | 0.82 |
HAS2-AS1 |
HAS2 antisense RNA 1 |
1365 |
0.48 |
chr2_25841069_25841672 | 0.82 |
DTNB |
dystrobrevin, beta |
31723 |
0.2 |
chr5_102202832_102203172 | 0.82 |
PAM |
peptidylglycine alpha-amidating monooxygenase |
1182 |
0.66 |
chr9_80437599_80437890 | 0.82 |
GNAQ |
guanine nucleotide binding protein (G protein), q polypeptide |
171 |
0.98 |
chr8_16612533_16612758 | 0.82 |
ENSG00000264092 |
. |
108360 |
0.07 |
chr5_82767889_82768074 | 0.81 |
VCAN |
versican |
237 |
0.96 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 6.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.3 | 3.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.2 | 3.5 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.1 | 3.4 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.9 | 3.6 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.8 | 2.4 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.8 | 2.4 | GO:1900115 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.8 | 2.3 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.8 | 1.5 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.7 | 0.7 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.7 | 2.0 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.7 | 2.7 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.6 | 3.7 | GO:0016264 | gap junction assembly(GO:0016264) |
0.6 | 2.5 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.6 | 1.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.6 | 0.6 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.6 | 1.7 | GO:0031223 | auditory behavior(GO:0031223) |
0.6 | 2.2 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.6 | 2.8 | GO:0007442 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.5 | 0.5 | GO:0010193 | response to ozone(GO:0010193) |
0.5 | 1.6 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.5 | 1.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.5 | 4.3 | GO:0060998 | regulation of dendritic spine development(GO:0060998) |
0.5 | 1.5 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.5 | 4.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.5 | 0.5 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.5 | 1.5 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.5 | 1.5 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.5 | 2.0 | GO:0048875 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.5 | 3.3 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.5 | 0.9 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.5 | 2.3 | GO:1903672 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.5 | 1.4 | GO:2000095 | regulation of non-canonical Wnt signaling pathway(GO:2000050) regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.4 | 0.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.4 | 1.3 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.4 | 1.3 | GO:0060596 | mammary placode formation(GO:0060596) |
0.4 | 3.0 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.4 | 2.5 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.4 | 1.6 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.4 | 1.2 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.4 | 1.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.4 | 0.8 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.4 | 1.2 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.4 | 1.5 | GO:0008218 | bioluminescence(GO:0008218) |
0.4 | 0.4 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.4 | 1.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.4 | 1.1 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.4 | 2.5 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.4 | 3.2 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.3 | 1.0 | GO:0008354 | germ cell migration(GO:0008354) |
0.3 | 7.7 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.3 | 0.3 | GO:0032344 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.3 | 1.0 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.3 | 1.0 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.3 | 2.0 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.3 | 2.6 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.3 | 0.9 | GO:0010842 | retina layer formation(GO:0010842) |
0.3 | 1.6 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.3 | 0.6 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 1.2 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.3 | 0.9 | GO:0060013 | righting reflex(GO:0060013) |
0.3 | 2.5 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.3 | 0.6 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.3 | 1.2 | GO:0010667 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.3 | 0.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.3 | 0.6 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.3 | 1.7 | GO:0045920 | negative regulation of exocytosis(GO:0045920) |
0.3 | 1.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.3 | 1.7 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.3 | 0.6 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.3 | 0.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 0.5 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.3 | 1.6 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.3 | 0.5 | GO:0072070 | loop of Henle development(GO:0072070) |
0.3 | 1.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.3 | 0.3 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.3 | 0.5 | GO:0060242 | contact inhibition(GO:0060242) |
0.3 | 2.1 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.3 | 0.8 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.3 | 0.8 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 0.5 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.2 | 1.2 | GO:0014850 | response to muscle activity(GO:0014850) |
0.2 | 1.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 0.2 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
0.2 | 0.2 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.2 | 0.2 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.2 | 0.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.7 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.2 | 0.7 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 0.7 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 0.9 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.2 | 0.7 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.2 | 0.2 | GO:0090190 | ureteric bud formation(GO:0060676) positive regulation of mesonephros development(GO:0061213) regulation of mesonephros development(GO:0061217) regulation of branching involved in ureteric bud morphogenesis(GO:0090189) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.2 | 3.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.2 | 0.2 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.2 | 0.5 | GO:0060437 | lung growth(GO:0060437) |
0.2 | 1.6 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.2 | 0.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.2 | 2.9 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.2 | 3.7 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.2 | 0.2 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.2 | 0.9 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.2 | 0.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.2 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.2 | 0.2 | GO:0060435 | bronchiole development(GO:0060435) |
0.2 | 0.8 | GO:0009158 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.2 | 0.8 | GO:0060347 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.2 | 2.9 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.2 | 4.4 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.2 | 0.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.4 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.2 | 0.8 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 0.6 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.2 | 0.8 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.2 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.2 | 0.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 0.4 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.2 | 1.1 | GO:0008347 | glial cell migration(GO:0008347) |
0.2 | 0.2 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.2 | 0.4 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.2 | 0.6 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.2 | 0.8 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.2 | 0.4 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.6 | GO:0060073 | urinary bladder smooth muscle contraction(GO:0014832) micturition(GO:0060073) smooth muscle contraction involved in micturition(GO:0060083) |
0.2 | 0.4 | GO:1903170 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.2 | 0.2 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.2 | 0.5 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.2 | 4.2 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.2 | 0.7 | GO:0006531 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.2 | 0.7 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.2 | 0.5 | GO:0001945 | lymph vessel development(GO:0001945) |
0.2 | 0.5 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 0.2 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
0.2 | 0.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 0.5 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.2 | 0.5 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 1.0 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.2 | 1.2 | GO:0010092 | organ induction(GO:0001759) specification of organ identity(GO:0010092) |
0.2 | 0.7 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.2 | 0.5 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 0.5 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.2 | 0.5 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.2 | 0.5 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 0.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 1.0 | GO:0060039 | pericardium development(GO:0060039) |
0.2 | 0.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 0.8 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.2 | 1.6 | GO:0043113 | receptor clustering(GO:0043113) |
0.2 | 0.5 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.2 | 0.5 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.2 | 0.2 | GO:0014041 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.2 | 0.3 | GO:0019471 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.2 | 1.7 | GO:0035329 | hippo signaling(GO:0035329) |
0.2 | 0.5 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 0.3 | GO:0060206 | estrous cycle phase(GO:0060206) |
0.2 | 0.2 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.2 | 0.2 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.2 | 0.3 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.7 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.1 | 0.9 | GO:0007350 | blastoderm segmentation(GO:0007350) tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 0.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.1 | GO:0010656 | negative regulation of muscle cell apoptotic process(GO:0010656) |
0.1 | 0.4 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.7 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.3 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.1 | 0.6 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.4 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 1.1 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.1 | 0.6 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.7 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.1 | 0.1 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 0.1 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 0.3 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.3 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.1 | 0.4 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.4 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.4 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.4 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.1 | 1.2 | GO:0071453 | cellular response to decreased oxygen levels(GO:0036294) cellular response to oxygen levels(GO:0071453) cellular response to hypoxia(GO:0071456) |
0.1 | 0.5 | GO:0047496 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.1 | 0.5 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.1 | 0.3 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 0.9 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 16.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.6 | GO:0032288 | myelin assembly(GO:0032288) |
0.1 | 0.3 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.1 | 0.1 | GO:2000300 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.4 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 1.1 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 0.8 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.1 | 2.6 | GO:0001843 | neural tube closure(GO:0001843) tube closure(GO:0060606) |
0.1 | 1.0 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.1 | GO:0060087 | relaxation of smooth muscle(GO:0044557) relaxation of vascular smooth muscle(GO:0060087) |
0.1 | 0.5 | GO:0001660 | fever generation(GO:0001660) |
0.1 | 0.2 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.1 | GO:0021546 | rhombomere development(GO:0021546) |
0.1 | 0.2 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.1 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.1 | 0.2 | GO:0048840 | otolith development(GO:0048840) |
0.1 | 0.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.6 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 0.2 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 0.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.3 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.7 | GO:0008038 | neuron recognition(GO:0008038) |
0.1 | 0.9 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.2 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.1 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 0.3 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.1 | 0.4 | GO:0032776 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.1 | 0.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 1.5 | GO:0060348 | bone development(GO:0060348) |
0.1 | 0.1 | GO:0032730 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.1 | 0.7 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.2 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 2.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.5 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 1.1 | GO:0031114 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
0.1 | 1.5 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.1 | 0.1 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.1 | 0.4 | GO:0000422 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.1 | 0.6 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.1 | 0.6 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.1 | 0.5 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.1 | 0.3 | GO:0090026 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.7 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.3 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.4 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 1.9 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.5 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.5 | GO:0003151 | outflow tract morphogenesis(GO:0003151) |
0.1 | 0.2 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 0.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 2.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.4 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.2 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.1 | 2.4 | GO:0001649 | osteoblast differentiation(GO:0001649) |
0.1 | 0.3 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.1 | 0.5 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 2.4 | GO:0022405 | hair follicle development(GO:0001942) molting cycle process(GO:0022404) hair cycle process(GO:0022405) skin epidermis development(GO:0098773) |
0.1 | 0.6 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.1 | 0.3 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.1 | 0.8 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.5 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.1 | 0.4 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.1 | 0.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 1.8 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.1 | 0.8 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) |
0.1 | 0.4 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 1.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.3 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.4 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.1 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.1 | 0.2 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.1 | 0.2 | GO:0060079 | excitatory postsynaptic potential(GO:0060079) |
0.1 | 0.2 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.1 | 0.3 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.1 | 0.2 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.4 | GO:0048636 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.1 | 1.6 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.1 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.3 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.4 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.3 | GO:0045901 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.1 | 0.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.2 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.4 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.1 | 0.8 | GO:0045429 | positive regulation of nitric oxide biosynthetic process(GO:0045429) positive regulation of reactive oxygen species biosynthetic process(GO:1903428) positive regulation of nitric oxide metabolic process(GO:1904407) |
0.1 | 0.2 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.1 | 0.2 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.1 | GO:0031645 | negative regulation of neurological system process(GO:0031645) |
0.1 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.3 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.2 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.1 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.1 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.2 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 0.2 | GO:0016246 | RNA interference(GO:0016246) |
0.1 | 0.2 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.1 | 1.0 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.2 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.2 | GO:0007494 | midgut development(GO:0007494) |
0.1 | 0.2 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.1 | 1.7 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.1 | 0.2 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 0.2 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 0.3 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.2 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.1 | 0.7 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.1 | 0.4 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.3 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.2 | GO:0007619 | courtship behavior(GO:0007619) male courtship behavior(GO:0008049) |
0.1 | 0.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 1.3 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.1 | 0.6 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.1 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.1 | 0.4 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 1.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 2.6 | GO:0030198 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.1 | 0.4 | GO:0015840 | urea transport(GO:0015840) |
0.1 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.3 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.1 | 0.3 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.1 | GO:1900120 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.1 | 0.1 | GO:2000379 | positive regulation of reactive oxygen species metabolic process(GO:2000379) |
0.1 | 1.1 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.1 | 0.4 | GO:0032373 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.1 | 0.2 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.2 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.4 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.8 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.1 | 0.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.2 | GO:0030146 | obsolete diuresis(GO:0030146) |
0.1 | 0.1 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.1 | 0.3 | GO:0060192 | negative regulation of lipoprotein lipase activity(GO:0051005) negative regulation of lipase activity(GO:0060192) |
0.1 | 0.1 | GO:0090201 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.1 | 0.1 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.1 | GO:0021754 | facial nucleus development(GO:0021754) |
0.1 | 0.2 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.1 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.1 | 0.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.1 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.1 | 0.1 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.1 | 0.4 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.5 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.2 | GO:0043114 | regulation of vascular permeability(GO:0043114) |
0.1 | 0.2 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 0.1 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.1 | 0.1 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.2 | GO:0048512 | circadian sleep/wake cycle(GO:0042745) circadian behavior(GO:0048512) |
0.1 | 0.1 | GO:0060795 | cell fate commitment involved in formation of primary germ layer(GO:0060795) |
0.1 | 0.6 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.1 | 0.3 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.3 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.1 | 0.1 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.1 | 1.0 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.1 | 0.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.5 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.1 | 0.2 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.1 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.1 | 0.2 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.1 | 0.3 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.1 | 0.3 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 1.1 | GO:0071772 | BMP signaling pathway(GO:0030509) response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
0.1 | 0.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.5 | GO:0014075 | response to amine(GO:0014075) |
0.1 | 0.1 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.1 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.8 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.7 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 0.2 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.2 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.3 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.0 | 0.2 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.4 | GO:0007613 | memory(GO:0007613) |
0.0 | 0.5 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.1 | GO:0071600 | otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.0 | 0.0 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.0 | 0.1 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 5.5 | GO:0006936 | muscle contraction(GO:0006936) |
0.0 | 0.0 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.0 | 0.7 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.1 | GO:0051955 | regulation of amino acid transport(GO:0051955) |
0.0 | 0.3 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.2 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.0 | 0.1 | GO:0016115 | vitamin catabolic process(GO:0009111) diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.1 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.0 | 0.1 | GO:0001885 | endothelial cell development(GO:0001885) |
0.0 | 0.2 | GO:0032963 | collagen metabolic process(GO:0032963) |
0.0 | 0.4 | GO:0050931 | melanocyte differentiation(GO:0030318) pigment cell differentiation(GO:0050931) |
0.0 | 0.0 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.0 | 0.1 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.1 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.1 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.0 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.0 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 0.2 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.0 | 0.0 | GO:0030878 | thyroid gland development(GO:0030878) |
0.0 | 0.2 | GO:0014032 | neural crest cell development(GO:0014032) |
0.0 | 0.1 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.2 | GO:0050432 | catecholamine secretion(GO:0050432) |
0.0 | 0.4 | GO:0001508 | action potential(GO:0001508) |
0.0 | 0.4 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.1 | GO:0050807 | regulation of synapse organization(GO:0050807) |
0.0 | 0.0 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.2 | GO:0035088 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 2.7 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.4 | GO:0007492 | endoderm development(GO:0007492) |
0.0 | 0.1 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.0 | 0.1 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.2 | GO:0035094 | response to nicotine(GO:0035094) |
0.0 | 0.1 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.0 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.0 | GO:0042519 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.0 | 0.0 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.0 | 0.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.0 | GO:0035567 | non-canonical Wnt signaling pathway(GO:0035567) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.2 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.0 | GO:0060438 | trachea development(GO:0060438) |
0.0 | 0.1 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.1 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.0 | 0.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.1 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.0 | 0.0 | GO:0035637 | transmission of nerve impulse(GO:0019226) multicellular organismal signaling(GO:0035637) |
0.0 | 0.2 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.1 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.0 | 0.2 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.1 | GO:0015791 | polyol transport(GO:0015791) |
0.0 | 0.0 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.0 | 0.3 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.0 | 0.1 | GO:0000097 | sulfur amino acid biosynthetic process(GO:0000097) |
0.0 | 0.1 | GO:0034105 | positive regulation of tissue remodeling(GO:0034105) |
0.0 | 0.1 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 0.2 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.3 | GO:0060828 | regulation of canonical Wnt signaling pathway(GO:0060828) |
0.0 | 0.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.1 | GO:0051904 | pigment granule transport(GO:0051904) |
0.0 | 0.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.3 | GO:0033189 | response to vitamin A(GO:0033189) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.3 | GO:0030178 | negative regulation of Wnt signaling pathway(GO:0030178) |
0.0 | 0.0 | GO:0055010 | ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
0.0 | 0.1 | GO:0051593 | response to folic acid(GO:0051593) |
0.0 | 0.3 | GO:0001657 | ureteric bud development(GO:0001657) mesonephric epithelium development(GO:0072163) mesonephric tubule development(GO:0072164) |
0.0 | 0.1 | GO:0051938 | L-glutamate import(GO:0051938) |
0.0 | 0.1 | GO:0090102 | cochlea development(GO:0090102) |
0.0 | 0.2 | GO:0045132 | meiotic chromosome segregation(GO:0045132) |
0.0 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.2 | GO:0046386 | deoxyribose phosphate catabolic process(GO:0046386) |
0.0 | 0.1 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.0 | 0.1 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.0 | 0.3 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.1 | GO:0031274 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.0 | GO:0097501 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.0 | 0.0 | GO:0043084 | penile erection(GO:0043084) |
0.0 | 0.2 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.0 | GO:0042506 | tyrosine phosphorylation of Stat5 protein(GO:0042506) |
0.0 | 0.0 | GO:0051905 | establishment of pigment granule localization(GO:0051905) |
0.0 | 0.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.0 | GO:0002024 | diet induced thermogenesis(GO:0002024) vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) adaptive thermogenesis(GO:1990845) |
0.0 | 0.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.1 | GO:0014743 | regulation of cardiac muscle hypertrophy(GO:0010611) regulation of muscle hypertrophy(GO:0014743) |
0.0 | 0.3 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 1.2 | GO:0006865 | amino acid transport(GO:0006865) |
0.0 | 0.1 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.0 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
0.0 | 0.3 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.0 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.1 | GO:0042551 | neuron maturation(GO:0042551) |
0.0 | 0.2 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.0 | GO:0032109 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.0 | 0.1 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.0 | 0.0 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.0 | 0.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.0 | 0.8 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.1 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.5 | GO:0010001 | glial cell differentiation(GO:0010001) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.0 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.0 | 0.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.0 | GO:0032274 | gonadotropin secretion(GO:0032274) |
0.0 | 0.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.0 | GO:0006949 | syncytium formation(GO:0006949) |
0.0 | 0.0 | GO:0000578 | embryonic axis specification(GO:0000578) |
0.0 | 0.0 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.1 | GO:0007416 | synapse assembly(GO:0007416) |
0.0 | 0.0 | GO:0051445 | regulation of meiotic cell cycle(GO:0051445) |
0.0 | 0.2 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.0 | 0.2 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.0 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.1 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.1 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.4 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.0 | 0.0 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.0 | 0.1 | GO:1901862 | negative regulation of striated muscle tissue development(GO:0045843) negative regulation of muscle tissue development(GO:1901862) |
0.0 | 0.0 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.0 | 0.1 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.0 | 0.1 | GO:0007530 | sex determination(GO:0007530) |
0.0 | 0.0 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.0 | 0.0 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.0 | 0.2 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.0 | 0.0 | GO:0031167 | rRNA methylation(GO:0031167) |
0.0 | 0.2 | GO:0042462 | photoreceptor cell development(GO:0042461) eye photoreceptor cell development(GO:0042462) |
0.0 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.0 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.0 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.1 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.1 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.4 | GO:0017148 | negative regulation of translation(GO:0017148) |
0.0 | 0.1 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 0.0 | GO:0046541 | saliva secretion(GO:0046541) |
0.0 | 0.0 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.2 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.0 | 0.0 | GO:0015837 | amine transport(GO:0015837) |
0.0 | 0.0 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) |
0.0 | 0.1 | GO:0009209 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
0.0 | 0.0 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.0 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.0 | 0.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.0 | GO:0042471 | ear morphogenesis(GO:0042471) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.4 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.9 | 4.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.8 | 2.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.6 | 5.2 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.6 | 1.8 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.5 | 1.6 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.5 | 1.6 | GO:0070852 | cell body fiber(GO:0070852) |
0.5 | 3.6 | GO:0005916 | fascia adherens(GO:0005916) |
0.5 | 1.0 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.5 | 3.4 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.4 | 2.1 | GO:0071437 | invadopodium(GO:0071437) |
0.4 | 2.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.4 | 1.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.4 | 1.4 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.3 | 1.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 0.5 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.3 | 1.0 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.2 | 1.4 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 1.4 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 2.3 | GO:0043034 | costamere(GO:0043034) |
0.2 | 1.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 0.9 | GO:0032059 | bleb(GO:0032059) |
0.2 | 0.2 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.2 | 0.8 | GO:0031430 | M band(GO:0031430) |
0.2 | 1.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 1.2 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 3.8 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 1.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 1.0 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 0.2 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.2 | 0.7 | GO:0043205 | fibril(GO:0043205) |
0.2 | 0.9 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 1.3 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.2 | 1.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 0.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 9.0 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 10.9 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 0.4 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.4 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 1.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.9 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.3 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 2.1 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 1.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.4 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 31.1 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.4 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 1.2 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 1.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.3 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 2.0 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 3.7 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.4 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.1 | 0.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 2.2 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 5.5 | GO:0030016 | myofibril(GO:0030016) |
0.1 | 0.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.1 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.1 | 2.6 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.8 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.1 | 0.6 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.3 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.2 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.1 | 10.8 | GO:0005911 | cell-cell junction(GO:0005911) |
0.1 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.4 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.3 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 3.3 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.3 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 0.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 0.1 | GO:0070938 | actomyosin contractile ring(GO:0005826) contractile ring(GO:0070938) |
0.1 | 1.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.6 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 0.4 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 0.7 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.2 | GO:0036126 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.0 | 0.0 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 9.7 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 3.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.5 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 1.1 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 20.0 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.4 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.0 | 0.2 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.3 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.4 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.0 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.6 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.8 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.4 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.1 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.1 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 1.0 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.1 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.3 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.0 | 0.4 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.0 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.0 | GO:0042584 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.0 | 0.1 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 2.7 | GO:0045202 | synapse(GO:0045202) |
0.0 | 0.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 0.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.0 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.1 | GO:0042383 | sarcolemma(GO:0042383) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 7.2 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
1.1 | 3.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.0 | 3.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.8 | 3.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.8 | 6.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.7 | 2.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.7 | 2.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.6 | 1.9 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.6 | 2.5 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.5 | 2.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.5 | 1.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.5 | 1.5 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.5 | 2.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.5 | 4.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.5 | 3.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.5 | 1.8 | GO:0042805 | actinin binding(GO:0042805) |
0.4 | 1.3 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.4 | 1.7 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.4 | 2.9 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.4 | 2.7 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.4 | 2.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.4 | 1.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.4 | 2.8 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.3 | 4.5 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.3 | 1.0 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 7.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.3 | 0.9 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.3 | 1.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 1.2 | GO:0030172 | troponin C binding(GO:0030172) |
0.3 | 1.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.3 | 0.9 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.3 | 0.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 1.1 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.3 | 0.8 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.3 | 1.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 0.8 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 1.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.3 | 0.8 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 0.8 | GO:0035198 | miRNA binding(GO:0035198) |
0.2 | 4.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 1.0 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 2.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 2.8 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 0.7 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 1.9 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 1.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 0.9 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.2 | 2.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.9 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.2 | 1.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 1.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 0.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 0.9 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 0.6 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 1.0 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 0.6 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 0.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 14.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 2.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 0.6 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.2 | 0.6 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 2.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 0.8 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.2 | 0.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 1.1 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.2 | 0.9 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 0.5 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.2 | 1.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.2 | 0.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 1.4 | GO:0001968 | fibronectin binding(GO:0001968) |
0.2 | 0.5 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.2 | 0.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 0.8 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.2 | 0.5 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.2 | 0.5 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 0.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.7 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.2 | 0.3 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 1.7 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 0.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 0.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 0.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 1.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 1.3 | GO:0016595 | glutamate binding(GO:0016595) |
0.2 | 0.5 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 0.5 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.2 | 0.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 0.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 0.6 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.2 | 0.3 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.6 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.4 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.1 | 0.7 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.1 | 1.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.1 | 0.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.9 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 1.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 1.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.6 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.4 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.1 | 1.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 5.2 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 0.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 1.0 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.6 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 1.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.9 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 0.8 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.8 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 1.0 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.5 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 1.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.3 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 0.4 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) |
0.1 | 0.7 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.9 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 1.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.8 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 1.0 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 1.7 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.5 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 3.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.4 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 3.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.5 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.5 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 0.3 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 1.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.9 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.9 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 1.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.2 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.1 | 1.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.3 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 0.6 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.1 | 0.2 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.2 | GO:0043734 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 0.7 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 1.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.9 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 2.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.1 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.5 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.1 | 0.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.3 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 1.5 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.3 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.3 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.4 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.1 | 0.1 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.1 | 1.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.7 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.2 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.1 | 1.0 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.5 | GO:0001077 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 0.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.1 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.1 | 0.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 3.8 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 0.2 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.1 | 0.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.6 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.1 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.2 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.2 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.1 | 0.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 6.5 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 0.8 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.1 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.1 | 0.2 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.1 | 0.9 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.2 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.3 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.3 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.1 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.2 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 12.7 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.0 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.1 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.6 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.2 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.5 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.0 | 0.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.0 | 0.1 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 1.4 | GO:0019825 | oxygen binding(GO:0019825) |
0.0 | 0.1 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.0 | 0.1 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.0 | 0.3 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.1 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.5 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.2 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.3 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.2 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 1.1 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.0 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.0 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 2.4 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 2.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.3 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.0 | 0.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.2 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.2 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.1 | GO:0022824 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.0 | 3.1 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 1.6 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.4 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.0 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.0 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.1 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.0 | 0.3 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.1 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.0 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.1 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.1 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 9.8 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.0 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.1 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.1 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.1 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.0 | GO:0043121 | neurotrophin binding(GO:0043121) nerve growth factor binding(GO:0048406) |
0.0 | 0.5 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.0 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.0 | 1.9 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 1.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 0.0 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.3 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.0 | 0.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.0 | GO:0052743 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.0 | 0.0 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.0 | 0.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.0 | GO:0051637 | obsolete Gram-positive bacterial cell surface binding(GO:0051637) |
0.0 | 0.1 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 5.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 0.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 14.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 2.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 8.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 2.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 5.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 2.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 4.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 2.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 0.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 5.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 3.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 1.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 15.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 3.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 2.9 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 2.7 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 2.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 1.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 2.3 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.1 | 2.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 2.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 12.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 2.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.9 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.7 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.6 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 5.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.0 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 8.2 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.0 | 0.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.2 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 7.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.5 | 0.5 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.4 | 12.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.4 | 5.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.4 | 3.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 1.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 6.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 15.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 0.3 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.2 | 3.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 2.5 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 1.3 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.2 | 2.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 2.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 3.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 1.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 4.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 0.6 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.2 | 3.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 2.5 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.2 | 0.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 2.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 3.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 0.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 1.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 2.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.1 | 2.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 2.6 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.1 | 2.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 2.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 1.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 0.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 1.0 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 0.6 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 1.6 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 2.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 0.2 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 0.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 2.2 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.1 | 0.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.7 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 1.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.7 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 0.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 1.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 0.6 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 1.9 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 0.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 0.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 1.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.4 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.7 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.2 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.0 | 0.1 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.0 | 1.1 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.7 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 0.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.7 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.8 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.0 | 0.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.1 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.0 | 0.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.2 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.0 | 0.3 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.0 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.5 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 0.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.4 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 1.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.1 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.1 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.4 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.0 | 0.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |